Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avnet (AVT) Cash & Equivalents (2016 - 2025)

Avnet (AVT) has disclosed Cash & Equivalents for 17 consecutive years, with $300000.0 as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 99.83% to $300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2025, down 99.83% year-over-year, with the annual reading at $3.5 million for FY2025, 98.87% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $300000.0 at Avnet, down from $175.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $310.9 million in Q2 2024, with the low at $300000.0 in Q4 2025.
  • Average Cash & Equivalents over 5 years is $129.4 million, with a median of $153.7 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 4865.3% in 2024, then tumbled 99.83% in 2025.
  • Over 5 years, Cash & Equivalents stood at $299.1 million in 2021, then crashed by 98.53% to $4.4 million in 2022, then skyrocketed by 279.55% to $16.7 million in 2023, then surged by 930.75% to $172.1 million in 2024, then crashed by 99.83% to $300000.0 in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $300000.0, $175.5 million, and $3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.